Innate Pharma S.A. ADS Share Price
NASDAQ: IPHAInnate Pharma S.A. ADS Stock Performance
Innate Pharma S.A. ADS Share Price Today
As of 9 October 2026, Innate Pharma S.A. ADS's share price is $1.54. The stock opened at $1.54, compared to its previous close of $1.60. During today's trading session, Innate Pharma S.A. ADS's share price traded between $1.54 and $1.54, with an average price of $1.54. Over the past 52 weeks, the stock has recorded a high of $2.60 and a low of $1.21. In terms of performance, Innate Pharma S.A. ADS's share price has risen by 4.76% over the last six months and is down 21.63% on a year-on-year basis.
Innate Pharma S.A. ADS Share Price Chart
About Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.
Innate Pharma S.A. ADS Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.58 | $1.54 | -6.95% |
Sep 2026 | $2.13 | $1.66 | -27.41% |
Aug 2026 | $1.73 | $2.28 | +30.29% |
Jul 2026 | $1.81 | $1.75 | -3.31% |
Jun 2026 | $1.80 | $1.81 | +3.72% |
May 2026 | $1.44 | $1.75 | +18.71% |
Apr 2026 | $1.37 | $1.47 | +16.67% |
Mar 2026 | $1.61 | $1.26 | -25.88% |
Feb 2026 | $1.84 | $1.70 | -9.09% |
Jan 2026 | $1.82 | $1.87 | +5.06% |
Dec 2025 | $1.95 | $1.78 | -9.18% |
Nov 2025 | $1.93 | $1.96 | -0.25% |